BridgeMD
New treatment option for Postpartum
Official title Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs
ClinicalTrials.gov ID: NCT06912776
What this study is testing
- What it's testing
- This study aims to create a novel visual education tool that builds on the urgent maternal warning signs identified by The Council on Patient Safety in Women's Health Care. Including effective images will improve the understanding of these grave warning signs/symptoms, improving anatomical accuracy while remaining simplistic for patients of varying levels of health care literacy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Postpartum women
- Nulliparity
- Age \>18 years of age
- English speaking patients
You likely can't join if
- Inability to provide informed written consent
- Refusal to participate in all study-related procedures
- Patients not fluent in English
- Patients with current or history of serious peripartum complications and/or events - such as DVT, PE, peripartum cardiomyopathy, etc. (in which the...
- Patient with comorbidities that potentially require anticoagulation i.e. coagulopathies and may be more prone to DVTs
- Patients with uncorrected visual or hearing impairment
See the full eligibility criteria
- Postpartum women
- Nulliparity
- Age \>18 years of age
- English speaking patients
- Inability to provide informed written consent
- Refusal to participate in all study-related procedures
- Patients not fluent in English
- Patients with current or history of serious peripartum complications and/or events - such as DVT, PE, peripartum cardiomyopathy, etc. (in which the patient may have received more than standard clinical counseling)
- Patient with comorbidities that potentially require anticoagulation i.e. coagulopathies and may be more prone to DVTs
- Patients with uncorrected visual or hearing impairment
- Healthcare providers (in which patients will have significant background knowledge)
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.